SK-MEL-29 (Q54954048)

From Wikidata

Jump to navigation Jump to search

cell line

SK-Mel-29
SKMEL-29
SKMEL29
SK29-MEL
AV-Mel

Language	Label	Description	Also known as
English	SK-MEL-29	cell line	SK-Mel-29 SKMEL-29 SKMEL29 SK29-MEL AV-Mel

Statements

1 reference

Cellosaurus release 49

14 July 2024

cancer cell line

1 reference

Cellosaurus release 49

14 July 2024

autologous cell line

1 reference

Cellosaurus release 49

14 July 2024

described by source

AU cell-surface antigen of human malignant melanoma: solubilization and partial characterization

1 reference

Cellosaurus release 49

14 July 2024

Cell surface antigens of human malignant melanoma. II. Serological typing with immune adherence assays and definition of two new surface antigens

1 reference

Cellosaurus release 49

14 July 2024

Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells

1 reference

Cellosaurus release 49

14 July 2024

Cytolytic T-cell clones against an autologous human melanoma: specificity study and definition of three antigens by immunoselection

1 reference

Cellosaurus release 49

14 July 2024

Loss of polymorphic restriction fragments in malignant melanoma: implications for tumor heterogeneity

1 reference

Cellosaurus release 49

14 July 2024

Human tumor lines for cancer research.

1 reference

Cellosaurus release 49

14 July 2024

Cell surface antigens of human ovarian and endometrial carcinoma defined by mouse monoclonal antibodies

1 reference

Cellosaurus release 49

14 July 2024

Detection of cell surface and intracellular antigens by human monoclonal antibodies. Hybrid cell lines derived from lymphocytes of patients with malignant melanoma

1 reference

Cellosaurus release 49

14 July 2024

Serological survey of normal humans for natural antibody to cell surface antigens of melanoma

1 reference

Cellosaurus release 49

14 July 2024

Distinction of seventy-one cultured human tumor cell lines by polymorphic enzyme analysis.

1 reference

Cellosaurus release 49

14 July 2024

Surface antigens of melanocytes and melanomas. Markers of melanocyte differentiation and melanoma subsets

1 reference

Cellosaurus release 49

14 July 2024

Concurrent loss of the PTEN and RB1 tumor suppressors attenuates RAF dependence in melanomas harboring (V600E)BRAF

1 reference

Cellosaurus release 49

14 July 2024

Loss of NF1 in cutaneous melanoma is associated with RAS activation and MEK dependence

1 reference

Cellosaurus release 49

14 July 2024

HLA-A, B, C and DR alloantigen expression on forty-six cultured human tumor cell lines

1 reference

Cellosaurus release 49

14 July 2024

Integrative genomics identifies molecular alterations that challenge the linear model of melanoma progression

1 reference

Cellosaurus release 49

14 July 2024

A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma

1 reference

Cellosaurus release 49

14 July 2024

Virtually 100% of melanoma cell lines harbor alterations at the DNA level within CDKN2A, CDKN2B, or one of their downstream targets

1 reference

Cellosaurus release 49

14 July 2024

established from medical condition

1 reference

Cellosaurus release 49

14 July 2024

derived from organism type

1 reference

Cellosaurus release 49

14 July 2024

Identifiers

1 reference

Cellosaurus release 49

14 July 2024

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54954048&oldid=2258560885"